Gute Nachrichten für HNO-Ärzte

G-BA attestiert Dupilumab beträchtlichen Zusatznutzen

HNO Nachrichten volume 51, pages44–45(2021)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Author information

Affiliations

  1. Zentrum f. Rhinologie und Allergologie, An den Quellen 10, 65183, Wiesbaden, Germany

    Prof. Dr. med. Ludger Klimek

  2. HNO-Klinik, Klinikum rechts der Isar - TU München, Ismaninger Str. 22, 81675, München, Germany

    Dr. med. Adam M. Chaker

Authors
  1. Prof. Dr. med. Ludger Klimek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. Adam M. Chaker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. PD Dr. med. Achim G. Beule
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. med. Barbara Wollenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prof. Dr. med. Ludger Klimek.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Klimek, L., Chaker, A., Beule, A. et al. G-BA attestiert Dupilumab beträchtlichen Zusatznutzen. HNO Nachrichten 51, 44–45 (2021). https://doi.org/10.1007/s00060-020-7442-1

Download citation